Experimenal studies On cell and gene therapies for retinal dystrophies with a particular focus On ABCA4 retinopathies.

Aneta Sciezynska, Dominika Ozieblo, Monika Oldak

Journal: Klinika oczna 2018;118(1):66-71

PMID: 29715412

Abstract

Retinal dystrophies lead to gradual irreversible vision deterioration. The ABCA4 retinopathies constitute an important group of retinal dystrophies. However, there are no effective therapies available for this group of diseases. Yet, with the advent of Molecular therapies, the development of prospective therapeutic approaches seems feasible. The paper summarizes recent advances in gene and cell therapy that may be implemented in retinal dystrophies, especially in ABCA4-associated diseases.

Link outs

Free resources

Medical:

https://medlineplus.gov/genesandgenetherapy.html

MeSH Terms: ATP-Binding Cassette Transporters, Cell- and Tissue-Based Therapy, Genetic Therapy, Humans, Macular Degeneration, Mutation, Retinal Dystrophies, Stargardt Disease